Depinfer

Depinfer is a precision medicine company utilizing artificial intelligence to identify novel therapeutic targets in oncology. The company's proprietary DepInfer platform integrates large-scale functional genomics and multi-omics data to infer genetic dependencies and synthetic lethal vulnerabilities in cancer cells. By uncovering targets that traditional genomic sequencing misses, Depinfer aims to develop highly targeted small molecule therapies for specific patient populations. The company is currently in the discovery and pre-clinical stages, focusing on building a robust pipeline of first-in-class oncology programs. Their approach leverages deep learning to decode the complexity of cancer and accelerate the drug discovery process.